May 23, 2025

BP Pills: Does Timing Matter? 

A large Canadian study of 3,357 patients found that taking blood pressure medication at bedtime did not reduce deaths or heart events compared to morning dosing.

Conexiant

May 23, 2025

BP Pills: Does Timing Matter? 

A large Canadian study of 3,357 patients found that taking blood pressure medication at bedtime did not reduce deaths or heart events compared to morning dosing.

Conexiant

May 23, 2025

Regular Exercise Slows Memory Decline in Seniors

In a study of older adults with memory problems, those who exercised regularly for 12 months had less cognitive decline than those who did not receive any intervention.

Conexiant

May 23, 2025

BMI, Glucose, Blood Pressure Linked to Multimorbidity

A 30-year cohort study found that life-course factors—including BMI, blood pressure, and glucose—significantly influence chronic disease accumulation, but much of the risk remains unexplained.

Conexiant

May 22, 2025

Voices on the Go: Top Podcasts for Physicians

Physicians are tuning to podcasts that combine clinical insight, career development, and storytelling.

Conexiant

May 20, 2025

Clinical Trials Missing in Half of AI Tools

Researchers analyzed FDA-approved AI-enabled medical devices and reported that clinical performance and subgroup data were frequently missing.

Conexiant

May 19, 2025

HIV/Hepatitis B Drug Class Shows Promise Against Alzheimer's

A longitudinal study across two major U.S. health databases found nucleoside reverse transcriptase inhibitors to be associated with reduced Alzheimer's disease incidence.

Conexiant

May 19, 2025

CAA Imaging Markers Linked to Plasma Biomarkers

A large cohort study in South Korea found that cerebral amyloid angiopathy imaging markers were linked to increased Alzheimer’s-related plasma biomarkers and cognitive decline, partly mediated by brain amyloid buildup.

Conexiant

May 16, 2025

FDA Clears First Blood Test for Alzheimer’s

The FDA has cleared the first blood-based test to aid in diagnosing Alzheimer’s disease, offering a less invasive alternative to positron emission tomography scans and cerebrospinal fluid testing for cognitively impaired patients.

Conexiant